ReShape Lifesciences to Webcast Live at Life Sciences Investor Forum on December 16th
ReShape invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
SAN CLEMENTE, Calif., Dec. 9, 2021 /PRNewswire/ -- ReShape Lifesciences (Formally known as EnteroMedics) (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that Bart Bandy, Chief Executive Officer and President and Tom Stankovich, Chief Financial Officer of ReShape Lifesciences, will present a company overview live at VirtualInvestorConferences.com, at 2:00 pm ET on December 16th.
DATE: Thursday, December 16th
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
About ReShape Life Sciences
About Life Sciences Investor Forum
A real-time solution for investor engagement, Life Sciences Investor Forum is part of the OTC Market Group's suite of investor relations services specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
View original content to download multimedia:https://www.prnewswire.com/news-releases/reshape-lifesciences-to-webcast-live-at-life-sciences-investor-forum-on-december-16th-301441199.html
Company Codes: NASDAQ-SMALL:RSLS